Starting a GLP-1 receptor agonist (semaglutide — Ozempic® / Wegovy®) or dual GIP/GLP-1 agonist (tirzepatide — Mounjaro® / Zepbound®) triggers a major shift in gastric motility and hypothalamic satiety signaling during the first 4 to 8 weeks.
Why Do Gastrointestinal Side Effects Happen?
GLP-1 medications intentionally slow down gastric emptying. When meal volume remains too large or high in dietary fat during the 24h–72h peak plasma concentration window (Cmax), patients experience mild nausea, fullness, reflux, or constipation.
4 Evidence-Based Habits for Smooth Adaptation
- Protein-First Micro-Meals: Always begin meals with lean protein (eggs, grilled chicken breast, Greek yogurt, cottage cheese, white fish, or whey isolate) and stop at the first cue of fullness.
- Structured Hydration (35 ml/kg or ~0.5 fl oz/lb): Because GLP-1 receptors also blunt thirst signals, silent dehydration is the #1 cause of post-injection headaches and constipation.
- Avoid Heavy Fats on Shot Day: Dietary fat further delays gastric emptying during the Cmax peak.
- Log Symptoms by Cycle Day: Sharing a structured Clinical PDF Handout with your prescribing physician makes dose titration decisions safer and faster.
